Skip to main content
Eli Lilly8-K: Material contract

Eli Lilly secures major financing via multi-series note offering, signaling significant capital for future investment.

What happened

Eli Lilly has entered into an underwriting agreement to issue multiple series of fixed and floating rate notes, indicating a major capital raise.

Source

SEC EDGARMay 20, 2026

Current report (Form 8-K)

Eli Lilly 8-K

Filing excerpt

Underwriting Agreement, dated May 6, 2026, among Eli Lilly and Company and Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein.

sec.gov/Archives/edgar/data/59478/000119312526232707/d148580d8k.htmRead the full source

Other signals in this filing (1)

Extracted by Autobound

From the Signal API record
Signal
8-K: Material contract

What this signalsFilings often name leadership changes, deals and spending plans.

Form
8-K
Filed
May 20, 2026

The full record

From the Signal API record

Details

CIK
59478
Accession number
0001193125-26-232707
Metric named
Total proceeds from multi-series note offering. The specific amount is not disclosed in this exhibit-focused filing but is expected to be substantial.
Timeframe
Current quarter
Filing year
2026
Why it matters
Vendor relationship signal
Signal category
Strategic

Topics and mentions

Vendors

  • Morgan Stanley & Co. LLC
  • Citigroup Global Markets Inc.
  • Deutsche Bank Securities Inc.
  • Goldman Sachs & Co. LLC
  • Deutsche Bank Trust Company Americas
  • Citibank
  • N.A.
  • Kirkland & Ellis LLP

Vendors named

  • Morgan Stanley & Co. LLC
  • Citigroup Global Markets Inc.
  • Deutsche Bank Securities Inc.
  • Goldman Sachs & Co. LLC
  • Deutsche Bank Trust Company Americas
  • Citibank, N.A.
  • Kirkland & Ellis LLP

Extraction

Confidence
High
Relevance
90%
Sentiment
Positive
Detected
May 26, 2026
signal_type
sec-8k
signal_subtype
materialContract

Use this data

Get every 8-K signal for Eli Lilly and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Eli Lilly this week?”

  2. Send it to your own tools

    The Signal API returns 8-K signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-8k record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/f67c6e49-1deb-468e-b5a9-bd0fb9c0ba37 returns this record as JSON. POST /v1/companies/enrich returns every signal for lilly.com.

{
  "signal_id": "f67c6e49-1deb-468e-b5a9-bd0fb9c0ba37",
  "signal_type": "sec-8k",
  "signal_subtype": "materialContract",
  "detected_at": "2026-05-26T10:04:43.205+00:00",
  "company": {
    "name": "Eli Lilly",
    "domain": "lilly.com"
  },
  "data": {
    "detail": "Eli Lilly has entered into an underwriting agreement to issue multiple series of fixed and floating rate notes, indicating a major capital raise. This infusion of cash likely precedes significant spending on strategic initiatives such as R&D, manufacturing expansion, or acquisitions, creating opportunities for vendors supporting large-scale corporate projects.",
    "metrics": {
      "timeframe": "current_quarter",
      "dollar_context": "Total proceeds from multi-series note offering. The specific amount is not disclosed in this exhibit-focused filing but is expected to be substantial."
    },
    "summary": "Eli Lilly secures major financing via multi-series note offering, signaling significant capital for future investment.",
    "excerpts": "Underwriting Agreement, dated May 6, 2026, among Eli Lilly and Company and Morgan Stanley & Co. LLC, Citigroup Global Markets Inc., Deutsche Bank Securities Inc. and Goldman Sachs & Co. LLC, as representatives of the several underwriters named therein.",
    "relevance": 0.9,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/59478/000119312526232707/d148580d8k.htm",
    "filing_date": "2026-05-20",
    "filing_year": 2026,
    "sales_relevance": "Vendor relationship signal",
    "signal_category": "strategic",
    "vendors_mentioned": [
      "Morgan Stanley & Co. LLC",
      "Citigroup Global Markets Inc.",
      "Deutsche Bank Securities Inc.",
      "Goldman Sachs & Co. LLC",
      "Deutsche Bank Trust Company Americas",
      "Citibank, N.A.",
      "Kirkland & Ellis LLP"
    ]
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.